Omnicell, Inc. has announced that Nchacha E. Etta has been appointed Executive Vice President and Chief Financial Officer of the Company, effective June 1.
Etta succeeds Peter J. Kuipers, who will be stepping down from his role as Executive Vice President and Chief Financial Officer.
Omnicell chairman, president, chief executive officer and founder, Randall Lipps, said:
“We are very pleased to welcome Nchacha to the Omnicell team and we look forward to benefiting from his finance and accounting expertise as well as the broader leadership experience he brings to our organisation.
“Nchacha is a commercially focused and collaborative leader who not only has a proven track record of delivering strong financial and operating results but also shares our passion for improving patients’ health.”
Etta has more than 20 years of experience leading and working in global finance organisations across healthcare and consumer products industries.
He most recently served as Chief Financial Officer of Essilor of America, Inc., a subsidiary of EssilorLuxottica SA, where he developed and executed long-range financial and commercial strategy.
Prior to his role at Essilor of America, Etta served as the Worldwide Vice President and Chief Financial Officer of Johnson & Johnson Vision, where he led finance operations with a 250-person global team.
Etta has also served in a number of financial roles of increasing responsibility at The Coca-Cola Company, Microsoft Corporation and Eli Lilly and Company.
Nchacha E. Etta said:
“Omnicell is a category creator that is working to transform the pharmacy care delivery model, and I am honoured to join the team in an effort to leverage my expertise to help drive the Company’s strategy forward.
“Omnicell’s mission is one that I deeply believe in, and I look forward to collaborating with Randall and the entire management team as we seek to capture the potential opportunities that lie ahead and drive long-term value creation.”
